Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Therapeutic Nuclear Medicines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Therapeutic Nuclear Medicines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Nuclear Medicines Overall Market Size
2.1 Global Therapeutic Nuclear Medicines Market Size: 2021 VS 2028
2.2 Global Therapeutic Nuclear Medicines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Therapeutic Nuclear Medicines Sales: 2017-2028
3 Company Landscape
3.1 Top Therapeutic Nuclear Medicines Players in Global Market
3.2 Top Global Therapeutic Nuclear Medicines Companies Ranked by Revenue
3.3 Global Therapeutic Nuclear Medicines Revenue by Companies
3.4 Global Therapeutic Nuclear Medicines Sales by Companies
3.5 Global Therapeutic Nuclear Medicines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Therapeutic Nuclear Medicines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Therapeutic Nuclear Medicines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Therapeutic Nuclear Medicines Players in Global Market
3.8.1 List of Global Tier 1 Therapeutic Nuclear Medicines Companies
3.8.2 List of Global Tier 2 and Tier 3 Therapeutic Nuclear Medicines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Therapeutic Nuclear Medicines Market Size Markets, 2021 & 2028
4.1.2 Radium-223
4.1.3 Lutetium-177
4.1.4 Iodine-131
4.1.5 Other
4.2 By Type - Global Therapeutic Nuclear Medicines Revenue & Forecasts
4.2.1 By Type - Global Therapeutic Nuclear Medicines Revenue, 2017-2022
4.2.2 By Type - Global Therapeutic Nuclear Medicines Revenue, 2023-2028
4.2.3 By Type - Global Therapeutic Nuclear Medicines Revenue Market Share, 2017-2028
4.3 By Type - Global Therapeutic Nuclear Medicines Sales & Forecasts
4.3.1 By Type - Global Therapeutic Nuclear Medicines Sales, 2017-2022
4.3.2 By Type - Global Therapeutic Nuclear Medicines Sales, 2023-2028
4.3.3 By Type - Global Therapeutic Nuclear Medicines Sales Market Share, 2017-2028
4.4 By Type - Global Therapeutic Nuclear Medicines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Therapeutic Nuclear Medicines Market Size, 2021 & 2028
5.1.2 Thyroid
5.1.3 Bone Metastasis
5.1.4 Lymphoma
5.1.5 Other
5.2 By Application - Global Therapeutic Nuclear Medicines Revenue & Forecasts
5.2.1 By Application - Global Therapeutic Nuclear Medicines Revenue, 2017-2022
5.2.2 By Application - Global Therapeutic Nuclear Medicines Revenue, 2023-2028
5.2.3 By Application - Global Therapeutic Nuclear Medicines Revenue Market Share, 2017-2028
5.3 By Application - Global Therapeutic Nuclear Medicines Sales & Forecasts
5.3.1 By Application - Global Therapeutic Nuclear Medicines Sales, 2017-2022
5.3.2 By Application - Global Therapeutic Nuclear Medicines Sales, 2023-2028
5.3.3 By Application - Global Therapeutic Nuclear Medicines Sales Market Share, 2017-2028
5.4 By Application - Global Therapeutic Nuclear Medicines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Therapeutic Nuclear Medicines Market Size, 2021 & 2028
6.2 By Region - Global Therapeutic Nuclear Medicines Revenue & Forecasts
6.2.1 By Region - Global Therapeutic Nuclear Medicines Revenue, 2017-2022
6.2.2 By Region - Global Therapeutic Nuclear Medicines Revenue, 2023-2028
6.2.3 By Region - Global Therapeutic Nuclear Medicines Revenue Market Share, 2017-2028
6.3 By Region - Global Therapeutic Nuclear Medicines Sales & Forecasts
6.3.1 By Region - Global Therapeutic Nuclear Medicines Sales, 2017-2022
6.3.2 By Region - Global Therapeutic Nuclear Medicines Sales, 2023-2028
6.3.3 By Region - Global Therapeutic Nuclear Medicines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Therapeutic Nuclear Medicines Revenue, 2017-2028
6.4.2 By Country - North America Therapeutic Nuclear Medicines Sales, 2017-2028
6.4.3 US Therapeutic Nuclear Medicines Market Size, 2017-2028
6.4.4 Canada Therapeutic Nuclear Medicines Market Size, 2017-2028
6.4.5 Mexico Therapeutic Nuclear Medicines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Therapeutic Nuclear Medicines Revenue, 2017-2028
6.5.2 By Country - Europe Therapeutic Nuclear Medicines Sales, 2017-2028
6.5.3 Germany Therapeutic Nuclear Medicines Market Size, 2017-2028
6.5.4 France Therapeutic Nuclear Medicines Market Size, 2017-2028
6.5.5 U.K. Therapeutic Nuclear Medicines Market Size, 2017-2028
6.5.6 Italy Therapeutic Nuclear Medicines Market Size, 2017-2028
6.5.7 Russia Therapeutic Nuclear Medicines Market Size, 2017-2028
6.5.8 Nordic Countries Therapeutic Nuclear Medicines Market Size, 2017-2028
6.5.9 Benelux Therapeutic Nuclear Medicines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Therapeutic Nuclear Medicines Revenue, 2017-2028
6.6.2 By Region - Asia Therapeutic Nuclear Medicines Sales, 2017-2028
6.6.3 China Therapeutic Nuclear Medicines Market Size, 2017-2028
6.6.4 Japan Therapeutic Nuclear Medicines Market Size, 2017-2028
6.6.5 South Korea Therapeutic Nuclear Medicines Market Size, 2017-2028
6.6.6 Southeast Asia Therapeutic Nuclear Medicines Market Size, 2017-2028
6.6.7 India Therapeutic Nuclear Medicines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Therapeutic Nuclear Medicines Revenue, 2017-2028
6.7.2 By Country - South America Therapeutic Nuclear Medicines Sales, 2017-2028
6.7.3 Brazil Therapeutic Nuclear Medicines Market Size, 2017-2028
6.7.4 Argentina Therapeutic Nuclear Medicines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Therapeutic Nuclear Medicines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Therapeutic Nuclear Medicines Sales, 2017-2028
6.8.3 Turkey Therapeutic Nuclear Medicines Market Size, 2017-2028
6.8.4 Israel Therapeutic Nuclear Medicines Market Size, 2017-2028
6.8.5 Saudi Arabia Therapeutic Nuclear Medicines Market Size, 2017-2028
6.8.6 UAE Therapeutic Nuclear Medicines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Therapeutic Nuclear Medicines Major Product Offerings
7.1.4 Novartis AG Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.1.5 Novartis AG Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Therapeutic Nuclear Medicines Major Product Offerings
7.2.4 Bayer Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.2.5 Bayer Key News
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Corporate Summary
7.3.2 China Isotope & Radiation Business Overview
7.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Major Product Offerings
7.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.3.5 China Isotope & Radiation Key News
7.4 Q BioMed
7.4.1 Q BioMed Corporate Summary
7.4.2 Q BioMed Business Overview
7.4.3 Q BioMed Therapeutic Nuclear Medicines Major Product Offerings
7.4.4 Q BioMed Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.4.5 Q BioMed Key News
7.5 Curium Pharmaceuticals
7.5.1 Curium Pharmaceuticals Corporate Summary
7.5.2 Curium Pharmaceuticals Business Overview
7.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Major Product Offerings
7.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.5.5 Curium Pharmaceuticals Key News
7.6 Jubilant DraxImage
7.6.1 Jubilant DraxImage Corporate Summary
7.6.2 Jubilant DraxImage Business Overview
7.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Major Product Offerings
7.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.6.5 Jubilant DraxImage Key News
7.7 Dongcheng
7.7.1 Dongcheng Corporate Summary
7.7.2 Dongcheng Business Overview
7.7.3 Dongcheng Therapeutic Nuclear Medicines Major Product Offerings
7.7.4 Dongcheng Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.7.5 Dongcheng Key News
7.8 Lantheus
7.8.1 Lantheus Corporate Summary
7.8.2 Lantheus Business Overview
7.8.3 Lantheus Therapeutic Nuclear Medicines Major Product Offerings
7.8.4 Lantheus Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.8.5 Lantheus Key News
7.9 Acrotech Biopharma.
7.9.1 Acrotech Biopharma. Corporate Summary
7.9.2 Acrotech Biopharma. Business Overview
7.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Major Product Offerings
7.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.9.5 Acrotech Biopharma. Key News
7.10 Progenics Pharmaceuticals
7.10.1 Progenics Pharmaceuticals Corporate Summary
7.10.2 Progenics Pharmaceuticals Business Overview
7.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Major Product Offerings
7.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.10.5 Progenics Pharmaceuticals Key News
7.11 International Isotopes
7.11.1 International Isotopes Corporate Summary
7.11.2 International Isotopes Therapeutic Nuclear Medicines Business Overview
7.11.3 International Isotopes Therapeutic Nuclear Medicines Major Product Offerings
7.11.4 International Isotopes Therapeutic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.11.5 International Isotopes Key News
8 Global Therapeutic Nuclear Medicines Production Capacity, Analysis
8.1 Global Therapeutic Nuclear Medicines Production Capacity, 2017-2028
8.2 Therapeutic Nuclear Medicines Production Capacity of Key Manufacturers in Global Market
8.3 Global Therapeutic Nuclear Medicines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Therapeutic Nuclear Medicines Supply Chain Analysis
10.1 Therapeutic Nuclear Medicines Industry Value Chain
10.2 Therapeutic Nuclear Medicines Upstream Market
10.3 Therapeutic Nuclear Medicines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Therapeutic Nuclear Medicines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer